Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03224299 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation
A Phase 2 study of Preoperative Skin Preparation, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 131
- Enrollment target
- 2
- Study locations
NCT03224299: Completed Phase 2 study of Preoperative Skin Preparation, sponsored by Becton, Dickinson and Company.
NCT03224299 is a Phase 2 study of Preoperative Skin Preparation that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 131 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03224299, a Phase 2 study of Preoperative Skin Preparation, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 131 participants
- Enrollment target
- 2
- Study locations
Study Summary
Objective of this study is to compare the antimicrobial properties of an investigational agent to an active control and a negative control when applied to specific body locations. Testing will be performed according to the procedures outlined in the Food and Drug Administration Tentative Final Monograph (TFM) for Effectiveness Testing of a Patient Preoperative Skin Preparation
Conditions Studied
Interventions
- OTHER Saline
- DRUG OCT - clear
- DRUG OCT- tinted
- OTHER ChloraPrep
Study Locations (2)
Montana
- BioScience Laboratories - Bozeman
- BioScience Laboratories - Butte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2017-06-21 |
| Est. Completion | 2017-10-03 |
| Phase | Phase 2 |
What the finished NCT03224299 record still lists
NCT03224299 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 1 condition, with Preoperative Skin Preparation appearing as the primary indexed condition, and to 4 interventions - of which Saline is the first listed.
NCT03224299 reports a single indexed study location in Montana.
Frequently Asked Questions
What is clinical trial NCT03224299 about?
NCT03224299 is a clinical study titled "Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation". Objective of this study is to compare the antimicrobial properties of an investigational agent to an active control and a negative control when applied to specific body locations. Testing will be performed according to the procedures outlined in the Food and Drug Administration Tentative Final Monog...
What is the current status of trial NCT03224299?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 131 participants. The study started on 2017-06-21. Estimated completion is 2017-10-03.
What conditions does trial NCT03224299 study?
This clinical trial studies the following conditions: Preoperative Skin Preparation.
What interventions are being tested in trial NCT03224299?
The interventions under investigation include: Saline (OTHER), OCT - clear (DRUG), OCT- tinted (DRUG), ChloraPrep (OTHER).
Who is sponsoring clinical trial NCT03224299?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03224299 being conducted?
This trial has 2 study locations across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03224299's enrollment target sits among peer trials
131 541st of 2000 higher than 1,458 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI